Showing results (341-350 of 3,567) with videos related to

Sort By:
Pageof 357
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 1, 1989
Chronological relationships between mediator release and changes in airway dynamics during an ascaris response in sensitive cynomolgus monkeysP E Malo
Prostaglandins, Leukotrienes, and Essential Fatty Acids|April 12, 2014
Potential for daily supplementation of n-3 fatty acids to reverse symptoms of dry eye in miceAkiko Harauma, Junpei Saito, Yoshitake Watanabe, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 4, 2014
Biological properties of a DHA-containing structured phospholipid (AceDoPC) to target the brainM Lagarde, M Hachem, N Bernoud-Hubac, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 15, 2017
Abdominal aortic aneurysm and omega-3 polyunsaturated fatty acids: Mechanisms, animal models, and potential treatmentLara T Meital, Shaun L Sandow, Philip C Calder, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|January 16, 2017
Could post-weaning dietary chia seed mitigate the development of dyslipidemia, liver steatosis and altered glucose homeostasis in offspring exposed to a sucrose-rich diet from utero to adulthood?M A Fortino, M E Oliva, S Rodriguez, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 13, 2014
Association between polyunsaturated fatty acid concentrations in maternal plasma phospholipids during pregnancy and offspring adiposity at age 7: the MEFAB cohortPaul S de Vries, Marij Gielen, Dimitris Rizopoulos, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 1, 1989
Relative effects of flurbiprofen on platelet 12-hydroxy-eicosatetraenoic acid and thromboxane A2 production: influence on collagen-induced platelet aggregation and adhesionJ Van Ryan-McKenna, M R Buchanan
Prostaglandins, Leukotrienes, and Essential Fatty Acids|June 1, 1989
Endometrial content of prostaglandin precursors during the menstrual cycleU Rosing, A Olund
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1989
Wy-48,252 (1,1,1-trifluoro-N-[3-(2-quinolinylmethoxy)phenyl]methane sulfonamide) an orally active leukotriene D4 antagonist: pharmacological characterization in vitro and in vivo in the guinea pigJ M Hand, S F Schwalm, M A Auen, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 6, 2017
Genetic polymorphisms of FADS1, FADS2, and FADS3 and fatty acid profiles in subjects received methadone maintenance therapyHui-Ting Yang, Ruey-Yun Wang, Shih-Yi Huang, et al.
Pageof 357